<p>In A and B, MIN6-Vec and MIN6-HSD1 cells were cultured for 3 d with or without DHC (100 nM) and the 11β-HSD1 inhibitor (1 μM). Relative cell numbers were determined using the MTT assay. N = 10, **P<0.01 in untreated MIN6-HSD1 vs. MIN6-Vec cells using one-way ANOVA. @P<0.01 in DHC-treated vs. untreated MIN6-HSD1 cells using one-way ANOVA. In C and D, cells were cultured for 3 d with or without DHC and the 11β-HSD1 inhibitor. The relative rate of cell proliferation was determined using BrdU incorporation into newly synthesized DNA. N = 10, @P<0.01 in DHC-treated vs. untreated MIN6-HSD1 cells using one-way ANOVA.</p
<p> (A) and (J) Real time PCR analysis of <i>3OST-5</i> in stable (A) and transient (J) <i>3OST-5</i...
Es of HepG2-H1 and HepG2-NC cells. (C) Growth curves of L02 cells measured after exposed to 0.1 pM T...
<p><b>A</b>, HUVECs were grown in serum free medium in the absence (white bars) or the presence of A...
<p><b>A</b>. MIN6-Vec and MIN6-HSD1 cells were cultured for 3 d with or without DHC (100 nM) and the...
<p>(a,b) 11β-HSD1 selective inhibitor was applied to NHEKs at indicated dose and proliferation of th...
<p>(a) The relative expression of 11β-HSD1 in NDHF assessed by rtPCR with 10% FBS or 1% FBS in cultu...
<p>(A-B) hTERT-HSCs (A) and primary HSCs (B) were transfected for 72 hours with siNrf2, siKeap1 or s...
<p>A, crystal violet assay. Treatment of vector group with DHC (3 µM) in EGM-2 medium significantly ...
<p>(A) FaDu, Cal-27, and Hep-2 cells were treated with indicated concentrations of DHA for 24 or 48h...
<p>A549 (A) and H1299 (B) cells were incubated with with different concentrations of CVT-11127 (CVT)...
<p>(A) H719 cells with deficient DNMT1, DKD of DNMT1/DNMT3A, DKD of DNMT1/DNMT3B, or TKD (triple kno...
<p>(A) The cell viability was assessed at 24, 48 and 72 h after transfected with siRNA and control b...
<p>HO8910 cells were transfected with control siRNA (HO8910<sup>siNC</sup>) or Hsp90 specific siRNA ...
Es of HepG2-H1 and HepG2-NC cells. (C) Growth curves of L02 cells measured after exposed to 0.1 pM T...
<p>Cell proliferation was determined using XTT<sup>R</sup> assay and monitoring absorbance at 490/69...
<p> (A) and (J) Real time PCR analysis of <i>3OST-5</i> in stable (A) and transient (J) <i>3OST-5</i...
Es of HepG2-H1 and HepG2-NC cells. (C) Growth curves of L02 cells measured after exposed to 0.1 pM T...
<p><b>A</b>, HUVECs were grown in serum free medium in the absence (white bars) or the presence of A...
<p><b>A</b>. MIN6-Vec and MIN6-HSD1 cells were cultured for 3 d with or without DHC (100 nM) and the...
<p>(a,b) 11β-HSD1 selective inhibitor was applied to NHEKs at indicated dose and proliferation of th...
<p>(a) The relative expression of 11β-HSD1 in NDHF assessed by rtPCR with 10% FBS or 1% FBS in cultu...
<p>(A-B) hTERT-HSCs (A) and primary HSCs (B) were transfected for 72 hours with siNrf2, siKeap1 or s...
<p>A, crystal violet assay. Treatment of vector group with DHC (3 µM) in EGM-2 medium significantly ...
<p>(A) FaDu, Cal-27, and Hep-2 cells were treated with indicated concentrations of DHA for 24 or 48h...
<p>A549 (A) and H1299 (B) cells were incubated with with different concentrations of CVT-11127 (CVT)...
<p>(A) H719 cells with deficient DNMT1, DKD of DNMT1/DNMT3A, DKD of DNMT1/DNMT3B, or TKD (triple kno...
<p>(A) The cell viability was assessed at 24, 48 and 72 h after transfected with siRNA and control b...
<p>HO8910 cells were transfected with control siRNA (HO8910<sup>siNC</sup>) or Hsp90 specific siRNA ...
Es of HepG2-H1 and HepG2-NC cells. (C) Growth curves of L02 cells measured after exposed to 0.1 pM T...
<p>Cell proliferation was determined using XTT<sup>R</sup> assay and monitoring absorbance at 490/69...
<p> (A) and (J) Real time PCR analysis of <i>3OST-5</i> in stable (A) and transient (J) <i>3OST-5</i...
Es of HepG2-H1 and HepG2-NC cells. (C) Growth curves of L02 cells measured after exposed to 0.1 pM T...
<p><b>A</b>, HUVECs were grown in serum free medium in the absence (white bars) or the presence of A...